pmc logo image
Logo of canmedajCMAJ home pageCMAJ information for authors page
Journal List > Can Med Assoc J > v.114(1); Jan 10, 1976

Formats:
Can Med Assoc J. 1976 January 10; 114(1): 43–44.
PMCID: PMC1956563
Copyright notice
Control of recurrent supraventricular tachycardia with amiodarone hydrochloride.
J. H. Swan and A. W. Chisholm
Abstract
Amiodarone hydrochloride, a new antiarrhythmic agent, controlled a recurrent supraventricular arrhythmia, refractory to conventional medical treatment, in a 57-year-old patient with an anomalous conduction system and idiopathic cardiomyopathy. For the 11 months that the patient has been taking the drug her arrhythmia has not recurred. This drug has produced no important side effects in this patient.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (891K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 43
43
icon of scanned page 44
44
 
Images in this article
FIG. 1
FIG. 1

FIG. 1
on p.43
FIG. 2
FIG. 2

FIG. 2
on p.44
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Singh BN, Hauswirth O. Comparative mechanisms of action of antiarrhythmic drugs. Am Heart J. 1974 Mar;87(3):367–382. [PubMed]
  • Rosenbaum MB, Chiale PA, Ryba D, Elizari MV. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol. 1974 Aug;34(2):215–223. [PubMed]
  • Baudine A, Chaillet F, Charlier R, Hosslet A. Recherches dans la série des benzofurannes. XXVI. Effets pharmacologiques généraux de l'amiodarone. Arch Int Pharmacodyn Ther. 1967 Oct;169(2):469–481. [PubMed]
  • Charlier R, Deltour G, Baudine A, Chaillet F. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile. Arzneimittelforschung. 1968 Nov;18(11):1408–1417. [PubMed]
  • Singh BN, Vaughan Williams EM. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. [PubMed]
  • Olsson SB, Brorson L, Varnauskas E. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Br Heart J. 1973 Dec;35(12):1255–1259. [PubMed]
  • Petta JM, Zaccheo VJ. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics. J Pharmacol Exp Ther. 1971 Feb;176(2):328–338. [PubMed]
  • Hazard J, Perlemuter L, Bernheim R, Guilhaume B, Richier D. Insuffisances thyroïdiennes secondaires à un traitement par l'amiodarone. 2 nouvelles observations. Nouv Presse Med. 1973 Mar 17;2(11):691–693. [PubMed]
  • Delage C, Lagacé R, Huard J. Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study. Can Med Assoc J. 1975 May 17;112(10):1205–1208. [PubMed]
  • Babel J, Stangos N. L'action de l'amiodarone sur les tissus oculaires. Schweiz Med Wochenschr. 1972 Feb 19;102(7):220–223. [PubMed]
Articles from Canadian Medical Association Journal are provided here courtesy of
Canadian Medical Association

PubMed articles by these authors